Live Breaking News & Updates on Impedimed

Stay updated with breaking news from Impedimed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ImpediMed to Present Chronic Breast Cancer-related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting

/PRNewswire/ ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, announced today that it will present. ....

United States , Jodi Perkins , Chirag Shah , Stevenl Chen , Digital Health Platform , Breast Cancer Program , Amendola Communications , Lymphatic Research , Vanderbilt University , American Cancer Society , American Society , Breast Surgeons , Annual Meeting , Prospective Randomized Screening Trial , Comprehensive Breast Cancer Program , Cleveland Clinic , Med Chief Medical Officer , Mayo Clinic , Health Care Amp Hospitals , Medical Equipment , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries , Olls And Research ,

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

/PRNewswire/ ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against breast cancer-related. ....

United States , Prnewswire Impedimed , Jodi Perkins , Steven Chen , Multinational Association Of Supportive Care In Cancer , Amendola Communications , Digital Health Platform , American Cancer Society , Important Information , Breast Cancer Patients , Lymphedema Awareness Month , Lancet Discovery Science , Multinational Association , Supportive Care , Breast Cancer Related Lymphedema , Chief Medical Officer ,

We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the. ....

How Well Is Impedimed , Should We Worry About Impedimed , Free Cash Flow , Cash Reserves ,

Investing in ImpediMed (ASX:IPD) a year ago would have delivered you a 146% gain

Unfortunately, investing is risky - companies can and do go bankrupt. But if you pick the right stock, you can make a. ....

Impedimed Limited , Share Price , Revenue Growth , Profit Growth , Shareholder Returns ,

ImpediMed Limited (ASX:IPD) Insider Purchases A$144,440.00 in Stock

ImpediMed Limited (ASX:IPD – Get Rating) insider David Anderson bought 920,000 shares of the stock in a transaction that occurred on Tuesday, June 20th. The stock was acquired at an average price of A$0.16 ($0.10) per share, for a total transaction of A$144,440.00 ($96,293.33). ImpediMed Price Performance The company has a quick ratio of 6.23, […] ....

United States , David Anderson , Impedimed Limited , Get Rating , Med Limited , North America , Impedimed Daily , Asx Ipd , Insider Trading , Nsider Trades ,